Tomohiko Ai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomohiko Ai has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Jie Cheng
Texas Heart Institute/St Luke's Episcopal Hospital, Houston, TX, USA
2 shared publicationsKaveh Samani
Texas Heart Institute/St Luke's Episcopal Hospital, Houston, TX, USA
2 shared publicationsMasato Watanuki
Division of Cardiac Electrophysiology, Takeda General Hospital, Kyoto, Japan
2 shared publications- Matteo Vatta
Department of Pediatrics (Cardiology)
2 shared publications - Minoru Horie
Department of Cardiovascular Medicine, Shiga University of Medical Science
2 shared publications Shigeru Ikeguchi
Division of Cardiac Electrophysiology, Takeda General Hospital, Kyoto, Japan
2 shared publications
Latest Publications
- 1 February 2009
- Published by Elsevier in Biophysical Journal
- Vol. 96 (3) , 665a
Drug-induced Brugada ECG Changes Associated With A Novel SCN5A Mutation In A Patient With Atrial Arrhythmias
- 1 February 2009
- Published by Elsevier in Biophysical Journal
- Vol. 96 (3) , 665a
Drug-induced Brugada ECG Changes Associated With A Novel SCN5A Mutation In A Patient With Atrial Arrhythmias
- 1 August 2008
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 1 (3) , 193-201
α-1-Syntrophin Mutation and the Long-QT Syndrome
Background— Long-QT syndrome (LQTS) is an inherited disorder associated with sudden cardiac death. The cytoskeletal protein syntrophin-α 1 (SNTA1) is known to interact with the cardiac sodium channel (hNa v 1.5), and we hypothesized that SNTA1 mutations might cause phenotypic LQTS in patients with genotypically normal hNa v 1.5 by secondarily disturbing sodium channel function. Methods and Results— Mutational analysis of SNTA1 was performed on 39 LQTS patients (QTc≥480 ms) with previously negative genetic screening for the known LQTS-causing genes. We identified a novel A257G- SNTA1 missense mutation, which affects a highly conserved residue, in 3 unrelated LQTS probands but not in 400 ethnic-matched control alleles. Only 1 of these probands had a preexisting family history of LQTS and sudden death with an additional intronic variant in KCNQ1. Electrophysiological analysis was performed using HEK-293 cells stably expressing hNa v 1.5 and transiently transfected with either wild-type or mutant SNTA1 and, in neonatal rat cardiomyocytes, transiently transfected with either wild-type or mutant SNTA1. In both HEK-293 cells and neonatal rat cardiomyocytes, increased peak sodium currents were noted along with a 10-mV negative shift of the onset and peak of currents of the current-voltage relationships. In addition, A257G-SNTA1 shifted the steady-state activation ( V h ) leftward by 9.4 mV, whereas the voltage-dependent inactivation kinetics and the late sodium currents were similar to wild-type SNTA1. Conclusion— SNTA1 is a new susceptibility gene for LQTS. A257G- SNTA1 can cause gain-of-function of Na v 1.5 similar to the LQT3.
- 1 August 2008
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 1 (3) , 193-201
α-1-Syntrophin Mutation and the Long-QT Syndrome
Background— Long-QT syndrome (LQTS) is an inherited disorder associated with sudden cardiac death. The cytoskeletal protein syntrophin-α 1 (SNTA1) is known to interact with the cardiac sodium channel (hNa v 1.5), and we hypothesized that SNTA1 mutations might cause phenotypic LQTS in patients with genotypically normal hNa v 1.5 by secondarily disturbing sodium channel function. Methods and Results— Mutational analysis of SNTA1 was performed on 39 LQTS patients (QTc≥480 ms) with previously negative genetic screening for the known LQTS-causing genes. We identified a novel A257G- SNTA1 missense mutation, which affects a highly conserved residue, in 3 unrelated LQTS probands but not in 400 ethnic-matched control alleles. Only 1 of these probands had a preexisting family history of LQTS and sudden death with an additional intronic variant in KCNQ1. Electrophysiological analysis was performed using HEK-293 cells stably expressing hNa v 1.5 and transiently transfected with either wild-type or mutant SNTA1 and, in neonatal rat cardiomyocytes, transiently transfected with either wild-type or mutant SNTA1. In both HEK-293 cells and neonatal rat cardiomyocytes, increased peak sodium currents were noted along with a 10-mV negative shift of the onset and peak of currents of the current-voltage relationships. In addition, A257G-SNTA1 shifted the steady-state activation ( V h ) leftward by 9.4 mV, whereas the voltage-dependent inactivation kinetics and the late sodium currents were similar to wild-type SNTA1. Conclusion— SNTA1 is a new susceptibility gene for LQTS. A257G- SNTA1 can cause gain-of-function of Na v 1.5 similar to the LQT3.
- 1 March 2002
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 25 (3) , 374-375
Successful radiofrequency current catheter ablation of accessory atrioventricular pathway in Ebstein's anomaly using electroanatomic mapping.
- 1 March 2002
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 25 (3) , 374-375
Successful radiofrequency current catheter ablation of accessory atrioventricular pathway in Ebstein's anomaly using electroanatomic mapping.
- 1 January 1998
- Published by The Japanese Society of Electrocardiology in Japanese Journal of Electrocardiology
- Vol. 18 (4) , 413-423
Radiofrequency catheter ablation to WPW syndrome: Analysis of multiple accessory atrioventricular pathways.
高周波力テーテル・アブレーションを施行したWPW症候群74症例につき複数副伝導路の有無とその特徴を検討した.74症例中12例が複数副伝導路所見を有した.左心側では6例12本の複数副伝導路を認めうち3例は副伝導路間距離が2cm未満の複数コンポーネントKent束であった.一方右心側では5例15本の複数副伝導路がみられたが全例副伝導路間距離20m以上の複数Kent束であり, Ebstein奇形やSTOW Kent束, Mahaim束などのvariant preexoitation合併例がみられた.1例で左右両心側に副伝導路を認めた.顕性WPW症候群では41例中10例 (24%) と潜在性WPW症候群 (33例中1例: 3%) に比べ有意に高率に複数副伝導路所見を認めた (p<0.01) .複数副伝導路群におけるそれぞれの副伝導路に対するカテーテル・アブレーションの急性期成功率及び慢性期再発率は単数副伝導路群と差がなく, 複数副伝導路例に対しても高周波力テーテル・アブレーションは積極的に試みるべき治療法と考えられる.
- 1 January 1998
- Published by The Japanese Society of Electrocardiology in Japanese Journal of Electrocardiology
- Vol. 18 (4) , 413-423
Radiofrequency catheter ablation to WPW syndrome: Analysis of multiple accessory atrioventricular pathways.
高周波力テーテル・アブレーションを施行したWPW症候群74症例につき複数副伝導路の有無とその特徴を検討した.74症例中12例が複数副伝導路所見を有した.左心側では6例12本の複数副伝導路を認めうち3例は副伝導路間距離が2cm未満の複数コンポーネントKent束であった.一方右心側では5例15本の複数副伝導路がみられたが全例副伝導路間距離20m以上の複数Kent束であり, Ebstein奇形やSTOW Kent束, Mahaim束などのvariant preexoitation合併例がみられた.1例で左右両心側に副伝導路を認めた.顕性WPW症候群では41例中10例 (24%) と潜在性WPW症候群 (33例中1例: 3%) に比べ有意に高率に複数副伝導路所見を認めた (p<0.01) .複数副伝導路群におけるそれぞれの副伝導路に対するカテーテル・アブレーションの急性期成功率及び慢性期再発率は単数副伝導路群と差がなく, 複数副伝導路例に対しても高周波力テーテル・アブレーションは積極的に試みるべき治療法と考えられる.